Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study.
Yuta YoshizawaMichihiro HosojimaHideyuki KabasawaNaohito TanabeDaisuke UgamuraYutaka KodaHisaki ShimadaTetsuya TakasawaTakahito ItoTadahiro KitamuraMasaki KobayashiYoshiki SuzukiIchiei NaritaAkihiko SaitoPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
UMIN000024284.
Keyphrases
- glycemic control
- open label
- double blind
- placebo controlled
- phase iii
- phase ii
- type diabetes
- clinical trial
- blood glucose
- phase ii study
- end stage renal disease
- weight loss
- study protocol
- peritoneal dialysis
- chronic kidney disease
- cross sectional
- insulin resistance
- randomized controlled trial
- squamous cell carcinoma
- adipose tissue